Benzinga | Aug 9, 2021 04:04PM EDT

Organogenesis Holdings Q2 EPS $0.15 Beats $0.07 Estimate, Sales $123.20M Beat $107.30M Estimate

Organogenesis Holdings (NASDAQ:ORGO) reported quarterly earnings of $0.15 per share which beat the analyst consensus estimate of $0.07 by 114.29 percent. This is a 400 percent increase over losses of $(0.05) per share from the same period last year. The company reported quarterly sales of $123.20 million which beat the analyst consensus estimate of $107.30 million by 14.82 percent. This is a 78.65 percent increase over sales of $68.96 million the same period last year.